NFE2L2 and breast carcinoma: In vitro studies with breast cancer cells have revealed that the loss of caveolin-1 results in the activation of NF-E2-related factor 2 (Nrf2), a transcription factor upstream of MnSOD, leading to an increase in the glycolytic rate, dependent on mitochondrial H2O2 production and AMPK activation.